Modified bile acids as carriers for peptides and drugs
- 1 May 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 46 (1-2) , 17-30
- https://doi.org/10.1016/s0168-3659(96)01599-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Bile acid derived HMG-CoA reductase inhibitorsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Synthesis and Biological Activity of Bile Acid-Derived HMG-CoA Reductase Inhibitors. The Role of 21-Methyl in Recognition of HMG-CoA Reductase and the Ileal Bile Acid Transport SystemJournal of Medicinal Chemistry, 1994
- Expression cloning of a mammalian proton-coupled oligopeptide transporterNature, 1994
- Intestinal absorption of β‐lactam antibiotics and oligopeptidesEuropean Journal of Biochemistry, 1992
- Influence of amino acid side-chain modification on the uptake system for β-lactam antibiotics and dipeptides from rabbit small intestineBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Receptor-mediated delivery of drugs to hepatocytesAdvanced Drug Delivery Reviews, 1989
- Identification of identical binding polypeptides for cephalosporins and dipeptides in intestinal brush-border membrane vesicles by photoaffinity labelingBiochimica et Biophysica Acta (BBA) - Biomembranes, 1987
- A New Approach to the Oral Administration of Insulin and Other Peptide DrugsScience, 1986
- Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogsJournal of Pharmacy and Pharmacology, 1985
- Peptide transport in intestinal and renal brush border membrane vesiclesLife Sciences, 1982